Which adaptogens are most commonly used in zero-proof drinks and do they actually work?

The adaptogen concept has a specific origin: Soviet military pharmacology in the 1950s–1960s, where researchers sought non-toxic substances that would increase resistance to physical, chemical, and biological stressors without addiction or adverse side effects. The strict pharmacological definition requires three properties: non-specific action (works across multiple stressor types), normalising effect (brings the body toward homeostasis rather than in one direction), and non-toxicity at normal doses.

Ashwagandha (KSM-66 extract, the most studied standardised form) has genuine clinical support. Five randomised controlled trials published 2012–2021 demonstrate significant cortisol reduction, improvements in perceived stress, and enhanced sleep quality at 300–600 mg/day over 8–12 weeks. The mechanism involves withanolides (steroidal lactones), particularly withaferin A, which modulate the HPA (hypothalamic-pituitary-adrenal) axis. The problem: these effects accumulate over weeks; there is no acute single-dose effect of ashwagandha that would be relevant to a single drink consumed once.

Rhodiola rosea is the exception. Some of its effects — particularly on acute mental fatigue and exercise endurance — show a meaningful single-dose response within 30–60 minutes at doses of 200–400 mg of standardised extract (3% rosavins, 1% salidroside). A drink containing this dose at this standardisation could theoretically deliver some of the acute effect. However, few commercial drinks hit this dose.

Lion's mane, reishi, and cordyceps all have interesting preclinical data and small human studies — but standard effective doses (1,000–5,000 mg/day for most) are far above what any drink formulation includes. Ginseng (Panax) has documented acute cognitive effects at 200–400 mg of standardised extract, similar to rhodiola, making it one of the more credible additions to functional drinks at adequate doses.

Related questions